Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in ZNTL — Zentalis Pharmaceuticals, Inc.

CIK 1423053 MIAMI, FL
Back to ZNTL Full portfolio

Position in ZNTL

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$4,053,074
+$1,401,330 QoQ
Shares Held
1,732,083
-11.8% QoQ
Ownership
2.43%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZNTL Over Time

Shares Held

Position Value (USD)

Derivatives in ZNTL

reported options exposure · as of Mar 31, 2026
CallValue
$30,420
CallShares
13,000
PutValue
$26,208
PutShares
11,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,784,241,435 across 374 Biotechnology names. ZNTL ranks #146 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INSM
INSMED Inc
 2,182,571 $356,894,009
2 ONC
BeOne Medicines Ltd.
 1,032,298 $306,561,536
3 BMRN
Biomarin Pharmaceutical Inc
 4,512,634 $254,918,694
4 JAZZ
Jazz Pharmaceuticals plc
 1,259,444 $238,097,887
5 MDGL
Madrigal Pharmaceuticals, Inc.
 453,843 $237,573,195
6 BBIO
BridgeBio Pharma, Inc.
 3,173,940 $235,696,783
7 TERN
Terns Pharmaceuticals, Inc.
 3,218,810 $169,695,662
8 PTGX
Protagonist Therapeutics, Inc
 1,551,900 $163,570,260

All Filings in ZNTL

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $26,208 11,200
2026-03-31 $4,053,074 1,732,083
2026-03-31 $30,420 13,000
2025-12-31 $2,651,744 1,964,255
2025-09-30 $3,136,707 2,077,290
2025-09-30 $49,830 33,000
2025-06-30 $25,520 22,000
2025-06-30 $536,313 462,340
2025-03-31 $18,444 11,600
2025-03-31 $12,561 7,900
2025-03-31 $112,982 71,058
2024-12-31 $9,746,682 3,216,727
2024-12-31 $22,422 7,400
2024-12-31 $20,907 6,900
2024-09-30 $10,000,476 2,717,521
2024-09-30 $208,288 56,600
2024-09-30 $72,496 19,700
2024-06-30 $136,197 33,300
2024-06-30 $18,416,913 4,502,913
2024-06-30 $26,994 6,600
2024-03-31 $36,248 2,300
2024-03-31 $400,304 25,400
2024-03-31 $60,714,280 3,852,429
2023-12-31 $55,778,996 3,681,782
2023-12-31 $78,780 5,200
2023-12-31 $859,005 56,700
2023-09-30 $43,236,340 2,155,351
2023-09-30 $246,738 12,300
2023-09-30 $226,678 11,300
2023-06-30 $400,582 14,200
2023-06-30 $60,067,439 2,129,296
2023-06-30 $31,031 1,100
2023-03-31 $22,875,879 1,329,993
2023-03-31 $6,880 400
2023-03-31 $245,960 14,300
2022-12-31 $24,168 1,200
2022-12-31 $501,486 24,900
2022-12-31 $12,843,679 637,720
2022-09-30 $11,973,668 552,801
2022-09-30 $1,108,992 51,200
2022-06-30 $564,810 20,100
2022-06-30 $21,431,729 762,695
2022-03-31 $1,056,606 22,900
2022-03-31 $23,578,693 511,025
2021-12-31 $1,714,824 20,400
2021-12-31 $50,405,401 599,636
2021-09-30 $852,992 12,800
2021-09-30 $419,832 6,300
2021-09-30 $73,490,124 1,102,793
2021-06-30 $65,594,535 1,232,980

Report a Problem

Category
Description
Email (optional, for follow-up)